Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs.
LCC was established in Liverpool, United Kingdom, in June 2014. The company has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional 3D fragments/scaffolds/BB’s to support NCE discovery & development. LCC’s main focus areas are in DEL scaffolds, enantiopair fragment libraries, linkers for hetero bifunctionals, and a 3Discovery™ Virtual Library of over 1.5 million lead-like molecules.
LCC can support you from hit identification through to lead optimisation, by giving access to nearest neighbour analogues (including enantiopairs), a range of synthetic handles, and offering hit expansion via our lead-like virtual library and Parallel Synthesis Laboratory. We have also invested heavily to become an industry leader in providing absolute stereochemical determination and quantification of enantiomeric excess measurements, resulting in over 2000 in-stock novel, diverse, chiral building blocks.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner